Literature DB >> 3889396

Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis.

T Y Lin, D F Chrane, J D Nelson, G H McCracken.   

Abstract

Seventy-nine children were enrolled in a study to compare seven vs ten days of ceftriaxone therapy for bacterial meningitis. On the basis of a computer-generated list of therapy assignments, 35 children with Haemophilus, pneumococcal, or group B streptococcal meningitis each were assigned to seven- or ten-day treatment regimens; nine children with meningococcal meningitis received seven days of therapy. The population characteristics and etiologic agents were similar for the two treatment groups, as were also the findings on examination and culture of cerebrospinal fluid at completion of therapy. There were no significant differences in the frequency and types of neurological complications between the two treatment groups; four patients in each group had two or more neurological abnormalities. The rates of nosocomial infections and prolonged and secondary fever were similar in those who received seven days of therapy compared with patients treated for the conventional ten days. Diarrhea occurred in 44% of those receiving the drug. Patients treated with the seven-day regimen were discharged from the hospital approximately two days earlier than those with the ten-day regimen.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3889396

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

1.  Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1990-03-01       Impact factor: 8.262

2.  Novel approaches to therapy of meningitis.

Authors:  G H McCracken
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

Review 3.  Bacterial meningitis: current controversies in approaches to treatment.

Authors:  A J Williams; S Nadel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

Review 5.  Bacterial meningitis in children: critical review of current concepts.

Authors:  Ram Yogev; Judith Guzman-Cottrill
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Ceftriaxone. A reappraisal of its antibacterial activity and pharmacokinetic properties, and an update on its therapeutic use with particular reference to once-daily administration.

Authors:  R N Brogden; A Ward
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

7.  Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results.

Authors:  E Martin; P Hohl; T Guggi; F H Kayser; M Fernex
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

8.  Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.

Authors:  H H Bräutigam; H Knothe; R Rangoonwala
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 9.  Bacterial meningitis. Practical guidelines for management.

Authors:  J Rockowitz; A R Tunkel
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

10.  Bacterial meningitis: is there a "best" antimicrobial therapy?

Authors:  H F Eichenwald
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.